Stocks · Health care · Pharmaceutical Preparations

Altimmune, Inc.

ALT Clue Score41
United States Fiscal year ends December CIK 0001326190 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Jerome Benedict Durso
13 Aug 2026
President and CEO
Buy
15,000
$2.95
$44.25K
John Gill
6 Apr 2026
Director
Buy
9,200
$3.41
$31.35K
Jerome Benedict Durso
1 Apr 2026
President and CEO
Buy
15,000
$3.14
$47.10K
Gregory L Weaver
1 Apr 2026
Chief Financial Officer
Buy
10,000
$3.15
$31.50K
Jerome Benedict Durso
6 Mar 2026
President and CEO
Buy
20,000
$3.54
$70.79K
Gregory L Weaver
6 Mar 2026
Chief Financial Officer
Buy
5,000
$3.54
$17.70K
Wayne Pisano
8 Jan 2026
Director
Buy
5,000
$4.08
$20.41K
Catherine A. Sohn
5 Jan 2026
Director
Buy
500
$4.24
$2.12K
Diane Jorkasky
29 Dec 2025
Director
Buy
527
$3.80
$2.00K
John Gill
23 Dec 2025
Director
Buy
12,500
$4.10
$51.25K
Jerome Benedict Durso
22 Dec 2025
Director
Buy
12,500
$4.13
$51.57K

What was left out

Form 4 filings counted 41
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 413,705
History held since 7 May 2007